Oxidative Stress, Post‐Translational Modifications, and Type 1 Diabetes Pathogenesis
Immunological Reviews · 2026
DOI: 10.1111/imr.70182 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2026. Verfasst von Colleen J Winstead und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Oxidative Stress, Diabetes Mellitus, Type 1, T-Lymphocytes. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, Breakthrough T1D (Formerly JDRF), National Science Foundation.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes (T1D) is an organ‐specific autoimmune disease that destroys insulin‐producing beta‐cells. Insulin is a vital hormone for regulating glycemia that often undergoes post‐translational modifications during processing from pre‐proinsulin to biologically active insulin. While necessary for proper glucose homeostasis, insulin is also an autoantigen recognized by autoreactive T cells in T1D. Cellular stress pathways including endoplasmic reticulum stress and oxidative stress mediated by an increase in reactive oxygen species (ROS) synthesis and/or a concomitant decrease in antioxidant function can further drive post‐translational modifications of various autoantigens in T1D including insulin. Innate immune‐derived ROS generation is an essential frontline defense against microbial infections, but ROS can also function as signaling intermediates to properly stimulate T cell responses. Oxidative stress‐induced post‐translational modifications are thought to trigger autoreactive T cells in T1D by generating novel neoepitopes, eliciting epitope spreading, or enhancing autoantigen interactions with antigen‐presenting cells. With the current technology, detecting post‐translationally modified proteins is challenging. In this review, we will explore the role of ROS and other post‐translational modifications involved in T1D. We will also discuss islet transplantation strategies being used for patients with T1D including novel cell sources for beta‐cell replacement and management of oxidative stress after transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Molecular Genetics, and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA.
ORCID-Profile: Colleen J Winstead, Miki Hodel, Hubert M Tse
Förderung
- NIDDK NIH HHS
- Breakthrough T1D (Formerly JDRF)
- National Science Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Winstead, C. J., Hodel, M., & Tse, H. M. (2026). Oxidative Stress, Post‐Translational Modifications, and Type 1 Diabetes Pathogenesis. Immunological Reviews. https://doi.org/10.1111/imr.70182
Vancouver
Winstead CJ, Hodel M, Tse HM. Oxidative Stress, Post‐Translational Modifications, and Type 1 Diabetes Pathogenesis. Immunological Reviews. 2026. doi:10.1111/imr.70182
BibTeX
@article{Winstead2026,
author = {Winstead, Colleen J and Hodel, Miki and Tse, Hubert M},
title = {Oxidative Stress, Post‐Translational Modifications, and Type 1 Diabetes Pathogenesis},
journal = {Immunological Reviews},
year = {2026},
doi = {10.1111/imr.70182}
}
EUVIMED